Related references
Note: Only part of the references are listed.Epithelial expression of interleukin-37b in inflammatory bowel disease
H. Imaeda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Glucocorticoid Regulates Interleukin-37 in Systemic Lupus Erythematosus
Lijun Song et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells
Nozomu Sakai et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Muebeccel Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Interleukin 37 expression protects mice from colitis
Eoin N. McNamee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity
Qian Wu et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Cytokine disturbances in systemic lupus erythematosus
Noam Jacob et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
Gabor G. Illei et al.
ARTHRITIS AND RHEUMATISM (2010)
High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein
Daniela Novick et al.
JOURNAL OF AUTOIMMUNITY (2010)
IL-37 is a fundamental inhibitor of innate immunity
Marcel F. Nold et al.
NATURE IMMUNOLOGY (2010)
Pathogenesis of human systemic lupus erythematosus: recent advances
Jose C. Crispin et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Activation Profile of Intracellular Mitogen-Activated Protein Kinases in Peripheral Lymphocytes of Patients with Systemic Lupus Erythematosus
Chun K. Wong et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Efficacy and safety of infliximab in active SLE: a pilot study
S. S. Uppal et al.
LUPUS (2009)
Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis
B Ostendorf et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Interleukin-1 homologues lL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide
P Bufler et al.
BIOCHEMICAL JOURNAL (2004)
p38 mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas(lpr) mice
Y Iwata et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Increased excretions of β2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis
CY Tsai et al.
NEPHRON (2000)
Share Paper
